potenti
involv
virus
inflammatori
airway
diseas
iad
previous
investig
either
serolog
pcr
nasopharyng
swab
ns
aim
studi
determin
preval
incid
viral
genom
detect
qpcr
equin
airway
associ
respiratori
clinic
sign
method
ns
tracheal
wash
tw
collect
monthli
standardbr
racehors
train
consecut
month
sampl
equid
herpesvirus
ehv
equin
rhiniti
virusa
b
erbv
equin
equin
coronaviru
equin
influenza
viru
systemat
investig
ns
tw
nasal
discharg
cough
tracheal
mucu
score
tw
neutrophil
proport
simultan
record
result
genom
virus
detect
least
throughout
studi
differ
virus
also
concomitantli
detect
monthli
incid
tw
respect
erbv
erav
neither
agreement
correl
ns
tw
found
respect
genom
detect
viral
load
detect
viral
genom
ns
associ
clinic
sign
cough
significantli
associ
tw
detect
dna
p
erbv
rna
p
detect
dna
tw
also
significantli
associ
excess
tracheal
mucu
p
conclus
detect
quantif
erbv
qpcr
tw
ns
consid
investig
hors
iad
lower
airway
troubl
especi
inflammatori
airway
diseas
iad
repres
one
main
caus
poorperform
racehors
syndrom
may
affect
hors
age
clinic
characteris
chronic
occasion
cough
normal
breath
rest
diagnost
confirm
requir
document
either
excess
tracheobronchi
mucu
abnorm
profil
bronchoalveolar
lavag
fluid
balf
cytolog
one
exclus
criteria
iad
evid
system
sign
infect
among
variou
extrins
riskfactor
increas
proport
bacteria
mainli
streptococcu
zooepidemicu
actinobacilluspasteurella
spp
isol
tracheal
wash
tw
repeatedli
associ
clinic
sign
iad
young
older
thoroughbr
racehors
recent
revis
consensu
statement
equin
iad
point
lack
conclus
evid
relationship
viral
infect
syndrom
experiment
inocul
recent
perform
either
equin
rhiniti
viru
erav
equid
herpesviru
lead
observ
respiratori
clinic
sign
andor
abnorm
cytolog
profil
persist
day
challeng
potenti
implic
differ
virus
airway
inflamm
andor
poor
race
perform
also
previous
investig
epidemiolog
manner
studi
either
base
serolog
analys
recent
direct
detect
viral
genom
pcr
nasal
swab
balf
sampl
signific
associ
recent
found
seroposit
erav
diagnosi
iad
use
antibodi
titr
larg
appear
limit
valu
clinic
context
syndrom
posit
pcr
nasal
swab
balf
also
significantli
associ
diagnosi
iad
recent
casecontrol
studi
convers
clinic
sign
respiratori
diseas
associ
either
presenc
level
shed
nasal
swab
date
use
quantit
pcr
respiratori
sampl
relat
iad
describ
limit
number
virus
furthermor
epidemiolog
data
viral
load
tracheal
sampl
current
avail
previous
found
potenti
relev
experiment
condit
aim
studi
determin
preval
incid
viral
genom
detect
respiratori
tract
racehors
train
correl
viral
load
nasopharyng
swab
ns
tw
associ
viru
detect
quantif
clinic
sign
airway
inflamm
hypothesis
respiratori
virus
might
signific
riskfactor
iad
cohort
french
standardbr
trotter
investig
monthli
basi
week
consecut
month
novemb
januari
three
veterinari
practition
locat
normandi
franc
systemat
visit
total
differ
train
yard
respect
among
yard
particip
whole
period
declin
respect
month
replac
other
yard
time
inclus
hors
per
yard
randomli
select
among
compli
inclus
criteria
least
year
old
activ
train
race
free
clinic
sign
respiratori
diseas
hors
leav
yard
longitudin
studi
replac
anoth
one
yard
accord
inclus
criteria
hors
examin
sampl
either
rest
least
h
exercis
venou
blood
sampl
collect
haematolog
assess
order
rule
system
diseas
although
clinic
healthi
time
inclus
hors
eventu
becam
clinic
affect
throughout
studi
presenc
respiratori
clinic
sign
includ
nasal
discharg
cough
time
sampl
time
systemat
notic
tracheal
mucu
systemat
score
grade
accord
previous
publish
scale
ns
taken
nasopharynx
use
tailormad
cm
long
stem
end
cm
long
cm
diamet
cotton
swab
coveto
montaigu
franc
immedi
place
ml
transport
medium
tw
collect
transendoscop
instil
reaspir
ml
steril
isoton
salin
kept
serum
tube
bacteriolog
edta
tube
respect
cytolog
molecular
biolog
sampl
kept
refriger
immedi
sent
laboratori
process
within
h
collect
tw
fluid
systemat
cytocentrifug
g
min
shandon
cytospin
waltham
usa
stain
differenti
cell
count
perform
leukocyt
standard
quantit
bacteri
investig
also
perform
tw
identif
quantif
perform
sampl
exhibit
differ
strain
sampl
isol
count
colonyform
unit
cfu
ml
consid
neg
isol
bacteria
classifi
either
common
pathogen
commens
qpcr
valid
respiratori
sampl
base
afnor
norm
detect
follow
virus
assess
addit
file
equid
herpesviru
ehv
equin
rhiniti
viru
erav
equin
rhiniti
viru
b
erbv
erboviru
equin
adenoviru
eadv
equin
mastadenoviru
b
equin
coronaviru
ecov
equin
influenza
viru
eiv
respect
ml
ns
transport
medium
ml
tw
centrifug
g
min
pellet
resuspend
supernat
extract
dnarna
made
sampl
use
rna
viral
mini
kit
qiagen
courtaboeuf
franc
accord
manufactur
instruct
concentr
dnarna
store
use
virusspecif
qpcr
perform
total
volum
includ
neg
control
distil
water
serial
dilut
synthet
dna
rna
respect
plasmid
transcript
plasmid
target
region
amplif
synthet
sequenc
myic
also
perform
confirm
absenc
pcr
inhibitor
nucleic
acid
extract
previous
describ
viral
load
respiratori
fluid
express
without
normalis
preselect
cell
number
amount
dna
base
afnor
norm
respiratori
sampl
systemat
classifi
investig
viru
one
follow
group
neg
characterist
amplif
curv
present
posit
detect
characterist
amplif
curv
present
posit
group
also
divid
follow
subcategori
nonquantifi
viral
load
limit
quantif
loq
quantifi
quantif
viral
load
loq
descript
statist
perform
relev
variabl
overal
preval
monthli
incid
determin
binomi
confid
interv
ci
calcul
continu
data
normal
distribut
assess
shapirowilk
w
test
log
transform
normalis
distribut
present
median
st
rd
quartil
correl
viral
load
measur
agreement
ns
tw
evalu
use
pearson
coeffici
cohen
kappa
coeffici
respect
associ
detectionquantif
pathogen
clinicaldiagnost
variabl
airway
inflamm
assess
use
test
calcul
correspond
odd
ratio
data
analys
conduct
use
prism
graphpad
la
jolla
usa
ncss
nss
llc
kaysvil
usa
softwar
valu
p
consid
signific
total
hors
contribut
studi
sampl
conduct
period
median
number
month
hors
sampl
month
fig
cohort
compos
geld
femal
male
median
age
year
time
recruit
fig
overal
preval
viral
genom
detect
ns
summaris
tabl
among
respiratori
virus
investig
detect
least
throughout
studi
ecov
eiv
never
detect
tw
detect
tw
least
hors
hors
erbv
hors
hors
hors
erav
respect
hors
total
tw
neg
least
one
viru
detect
tw
sampl
among
genom
one
singl
viru
detect
sampl
dnarna
differ
virus
concomitantli
detect
tw
fig
overal
preval
viral
genom
detect
tw
summaris
tabl
respect
viral
load
detail
fig
poor
agreement
accord
coeffici
found
pair
sampl
ns
tw
detect
viral
genom
qpcr
posit
vs
neg
addit
file
concern
quantifi
sampl
signific
correl
found
among
viral
load
pair
sampl
ns
tw
investig
virus
detect
dna
tw
significantli
associ
cough
ci
p
detect
ci
quantif
ci
erbv
rna
tw
p
isol
commens
bacteria
tw
also
significantli
associ
cough
ci
p
associ
viru
bacteria
tw
nasal
discharg
similarli
signific
associ
either
viral
genom
detect
quantif
ns
clinic
sign
respiratori
diseas
quantif
least
one
viru
tw
quantifi
sampl
significantli
associ
tw
neutrophil
count
ci
p
detect
dna
tw
significantli
associ
excess
tracheal
mucu
ci
p
viral
load
tw
also
fairli
correl
neutrophil
proport
r
ci
p
convers
isol
commens
bacteria
neg
associ
tw
neutrophil
count
ci
p
associ
tracheal
mucu
score
viru
bacteria
tw
viral
genom
detectionquantif
ns
studi
provid
incid
preval
viral
genom
detect
qpcr
correspond
viral
load
ns
tw
hors
train
total
virus
investig
detect
least
respiratori
sampl
along
ecov
eiv
genom
never
found
ns
tw
throughout
studi
latter
unexpect
sinc
hors
activ
train
race
thu
vaccin
everi
month
time
sampl
altern
differ
viral
genom
concomitantli
detect
either
ns
tw
previou
studi
document
concurr
infect
erbv
either
eiv
knowledg
present
studi
first
report
concomit
genom
detect
along
erbv
among
bacteria
rel
low
preval
found
isol
streptococcu
zooepidemicu
tw
compar
previou
longitudin
studi
howev
cutoff
valu
cfuml
use
discrimin
neg
posit
sampl
describ
previous
similarli
identif
quantif
also
perform
sampl
differ
strain
moder
even
signific
associ
identif
commens
streptococcu
zooepidemicu
significantli
associ
cough
present
odd
airway
inflamm
also
significantli
increas
along
cfuml
genom
detect
highli
preval
present
longitudin
studi
accord
previous
publish
data
despit
moder
lower
monthli
incid
detect
least
one
occas
hors
studi
due
capabl
viral
latenc
might
determin
hors
perman
carrier
previous
publish
data
also
reveal
multipl
strain
might
concomitantli
detect
nasal
swab
tw
singl
hors
howev
phylogeni
perform
characteris
strain
detect
among
time
present
studi
detect
dna
tw
associ
cough
excess
tracheal
mucu
viral
load
significantli
correl
tw
neutrophil
proport
data
confirm
previou
cytolog
find
experiment
induc
reactiv
also
coher
recent
casecontrol
studi
nasal
shed
significantli
associ
diagnosi
iad
base
grow
evid
implic
lower
airway
inflamm
elucid
underli
pathogenesi
warrant
investig
hand
detect
quantif
viral
load
either
ns
tw
associ
cough
nasal
discharg
airway
inflamm
studi
observ
might
howev
surpris
sinc
repeatedli
detect
asymptomat
hors
altern
clinic
sign
frequent
report
equin
multinodular
pulmonari
fibrosi
associ
chronic
diseas
includ
intermitt
fever
weight
loss
respiratori
distress
genom
detect
erbv
tw
significantli
associ
cough
studi
increas
higher
viral
load
consid
preval
erbv
rna
quantif
present
found
ns
slightli
higher
previou
data
might
partial
explain
differ
sampl
methodolog
nasal
vs
nasopharyng
swab
qpcr
assay
convers
monthli
incid
quantifi
sampl
erbv
compar
previous
report
serolog
result
base
complement
fixat
test
howev
recent
found
detect
erbv
rna
pcr
nasal
swab
might
coincid
seroconvers
besid
low
preval
erav
rna
detect
ns
tw
somehow
unexpect
sinc
previous
associ
acut
clinic
case
respiratori
diseas
addit
high
seropreval
previous
describ
worldwid
viru
vaccin
current
avail
europ
accord
result
previou
longitudin
studi
signific
associ
found
viral
genom
detectionquantif
ns
clinic
sign
excess
tracheal
mucu
increas
tw
neutrophil
proport
interestingli
neither
agreement
correl
found
pair
sampl
ns
tw
genom
detect
viral
load
investig
viru
term
subclin
infecti
diseas
find
upper
airway
ns
consid
repres
lower
airway
tw
hors
moreov
viral
genom
detect
ns
seem
relev
clinic
context
iad
unlik
acut
infecti
airway
troubl
might
recommend
perform
qpcr
tw
sampl
viru
detect
hors
train
previous
suggest
limit
number
herpesvirus
one
limit
present
studi
would
lack
viru
isol
serolog
assay
addit
qpcr
perform
respiratori
fluid
demonstr
increas
antibodi
titr
howev
requir
two
consecut
sampl
interv
irrelev
field
concomit
diagnosi
iad
apart
virus
bacteria
noninfecti
agent
also
like
relev
develop
iad
hors
anoth
limit
would
absenc
environment
investig
within
differ
train
yard
throughout
studi
ultrafin
particl
within
breath
zone
hors
inde
recent
found
signific
riskfactor
excess
mucu
increas
tw
neutrophil
proport
